Global Gene Therapy in Oncology Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The Gene Therapy in Oncology is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of XX.0% during the forecast period. The research provides insights for the global Gene Therapy in Oncology market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Gene Therapy in Oncology industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Global Gene Therapy in Oncology Market Segmentations:

    By Players:

    • Editas Medicine

    • Shenzhen SiBiono GeneTech

    • CRISPR Therapeutics

    • Ziopharm Oncology

    • Bio-Path Holdings

    • Marsala Biotech

    • Bristol-Myers Squibb

    • Mologen AG

    • Advantagene

    • AstraZeneca

    • Geron Corp

    • Tocagen

    • Johnson & Johnson

    • UniQure

    • Cold Genesys

    • Amgen

    • Oncotelic

    • Idera Pharmaceuticals

    • Sillajen Biotherapeutics

    • Oncosec

    • Merck

    • Intellia Therapeutics

    • Oncolytics Biotech

    By Types:

    • Ex Vivo

    • In Vivo

    By End-User:

    • Hospitals

    • Diagnostics Centers

    • Research Institutes

    By Regions:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Gene Therapy in Oncology Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Gene Therapy in Oncology Market Size and Growth Rate of Ex Vivo from 2014 to 2026

      • 1.3.2 Global Gene Therapy in Oncology Market Size and Growth Rate of In Vivo from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Gene Therapy in Oncology Market Size and Growth Rate of Hospitals from 2014 to 2026

      • 1.4.2 Global Gene Therapy in Oncology Market Size and Growth Rate of Diagnostics Centers from 2014 to 2026

      • 1.4.3 Global Gene Therapy in Oncology Market Size and Growth Rate of Research Institutes from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Gene Therapy in Oncology Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States Gene Therapy in Oncology Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada Gene Therapy in Oncology Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico Gene Therapy in Oncology Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Gene Therapy in Oncology Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany Gene Therapy in Oncology Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK Gene Therapy in Oncology Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France Gene Therapy in Oncology Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy Gene Therapy in Oncology Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries Gene Therapy in Oncology Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain Gene Therapy in Oncology Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 Belgium Gene Therapy in Oncology Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland Gene Therapy in Oncology Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia Gene Therapy in Oncology Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey Gene Therapy in Oncology Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Gene Therapy in Oncology Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China Gene Therapy in Oncology Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan Gene Therapy in Oncology Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand Gene Therapy in Oncology Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India Gene Therapy in Oncology Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries Gene Therapy in Oncology Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea Gene Therapy in Oncology Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa Gene Therapy in Oncology Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries Gene Therapy in Oncology Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil Gene Therapy in Oncology Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria Gene Therapy in Oncology Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa Gene Therapy in Oncology Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina Gene Therapy in Oncology Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Gene Therapy in Oncology Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Gene Therapy in Oncology by Major Types

      • 3.4.1 Gene Therapy in Oncology Market Size and Growth Rate of Ex Vivo

      • 3.4.2 Gene Therapy in Oncology Market Size and Growth Rate of In Vivo

    4 Segmentation of Gene Therapy in Oncology Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Gene Therapy in Oncology by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Gene Therapy in Oncology in Hospitals

      • 4.4.2 Market Size and Growth Rate of Gene Therapy in Oncology in Diagnostics Centers

      • 4.4.3 Market Size and Growth Rate of Gene Therapy in Oncology in Research Institutes

    5 Market Analysis by Major Regions

    • 5.1 Global Gene Therapy in Oncology Production Analysis by Major Regions

    • 5.2 Global Gene Therapy in Oncology Consumption Analysis by Major Regions

    • 5.3 Global Gene Therapy in Oncology Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Gene Therapy in Oncology Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Gene Therapy in Oncology Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Gene Therapy in Oncology Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Gene Therapy in Oncology Production, Import, Consumption and Export Analysis

    6 Product Commodity of Gene Therapy in Oncology Market in Major Countries

    • 6.1 Top 5 Export Countries in Gene Therapy in Oncology market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Gene Therapy in Oncology market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Gene Therapy in Oncology market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Gene Therapy in Oncology market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Gene Therapy in Oncology market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Gene Therapy in Oncology market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7 North America Gene Therapy in Oncology Landscape Analysis

    • 7.1 North America Gene Therapy in Oncology Landscape Analysis by Major Types

    • 7.2 North America Gene Therapy in Oncology Landscape Analysis by Major End-Users

    • 7.3 North America Gene Therapy in Oncology Landscape Analysis by Major Countries

      • 7.3.1 United States Gene Therapy in Oncology Market Volume and Growth Rate

      • 7.3.2 Canada Gene Therapy in Oncology Market Volume and Growth Rate

      • 7.3.3 Mexico Gene Therapy in Oncology Market Volume and Growth Rate

    8 Europe Gene Therapy in Oncology Landscape Analysis

    • 8.1 Europe Gene Therapy in Oncology Landscape Analysis by Major Types

    • 8.2 Europe Gene Therapy in Oncology Landscape Analysis by Major End-Users

    • 8.3 Europe Gene Therapy in Oncology Landscape Analysis by Major Countries

      • 8.3.1 Germany Gene Therapy in Oncology Market Volume and Growth Rate

      • 8.3.2 UK Gene Therapy in Oncology Market Volume and Growth Rate

      • 8.3.3 France Gene Therapy in Oncology Market Volume and Growth Rate

      • 8.3.4 Italy Gene Therapy in Oncology Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Gene Therapy in Oncology Market Volume and Growth Rate

      • 8.3.6 Spain Gene Therapy in Oncology Market Volume and Growth Rate

      • 8.3.7 Belgium Gene Therapy in Oncology Market Volume and Growth Rate

      • 8.3.8 Poland Gene Therapy in Oncology Market Volume and Growth Rate

      • 8.3.9 Russia Gene Therapy in Oncology Market Volume and Growth Rate

      • 8.3.10 Turkey Gene Therapy in Oncology Market Volume and Growth Rate

    9 Asia Pacific Gene Therapy in Oncology Landscape Analysis

    • 9.1 Asia Pacific Gene Therapy in Oncology Landscape Analysis by Major Types

    • 9.2 Asia Pacific Gene Therapy in Oncology Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Gene Therapy in Oncology Landscape Analysis by Major Countries

      • 9.3.1 China Gene Therapy in Oncology Market Volume and Growth Rate

      • 9.3.2 Japan Gene Therapy in Oncology Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Gene Therapy in Oncology Market Volume and Growth Rate

      • 9.3.4 India Gene Therapy in Oncology Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Gene Therapy in Oncology Market Volume and Growth Rate

      • 9.3.6 South Korea Gene Therapy in Oncology Market Volume and Growth Rate

    10 Latin America, Middle East & Africa Gene Therapy in Oncology Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Gene Therapy in Oncology Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Gene Therapy in Oncology Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Gene Therapy in Oncology Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Gene Therapy in Oncology Market Volume and Growth Rate

      • 10.3.2 Brazil Gene Therapy in Oncology Market Volume and Growth Rate

      • 10.3.3 Nigeria Gene Therapy in Oncology Market Volume and Growth Rate

      • 10.3.4 South Africa Gene Therapy in Oncology Market Volume and Growth Rate 

      • 10.3.5 Argentina Gene Therapy in Oncology Market Volume and Growth Rate

    11 Major Players Profile

    • 11.1 Editas Medicine

      • 11.1.1 Editas Medicine Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Shenzhen SiBiono GeneTech

      • 11.2.1 Shenzhen SiBiono GeneTech Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 CRISPR Therapeutics

      • 11.3.1 CRISPR Therapeutics Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Ziopharm Oncology

      • 11.4.1 Ziopharm Oncology Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Bio-Path Holdings

      • 11.5.1 Bio-Path Holdings Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Marsala Biotech

      • 11.6.1 Marsala Biotech Company Profile and Recent Development

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Bristol-Myers Squibb

      • 11.7.1 Bristol-Myers Squibb Company Profile and Recent Development

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 Mologen AG

      • 11.8.1 Mologen AG Company Profile and Recent Development

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Advantagene

      • 11.9.1 Advantagene Company Profile and Recent Development

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 AstraZeneca

      • 11.10.1 AstraZeneca Company Profile and Recent Development

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction

    • 11.11 Geron Corp

      • 11.11.1 Geron Corp Company Profile and Recent Development

      • 11.11.2 Market Performance

      • 11.11.3 Product and Service Introduction

    • 11.12 Tocagen

      • 11.12.1 Tocagen Company Profile and Recent Development

      • 11.12.2 Market Performance

      • 11.12.3 Product and Service Introduction

    • 11.13 Johnson & Johnson

      • 11.13.1 Johnson & Johnson Company Profile and Recent Development

      • 11.13.2 Market Performance

      • 11.13.3 Product and Service Introduction

    • 11.14 UniQure

      • 11.14.1 UniQure Company Profile and Recent Development

      • 11.14.2 Market Performance

      • 11.14.3 Product and Service Introduction

    • 11.15 Cold Genesys

      • 11.15.1 Cold Genesys Company Profile and Recent Development

      • 11.15.2 Market Performance

      • 11.15.3 Product and Service Introduction

    • 11.16 Amgen

      • 11.16.1 Amgen Company Profile and Recent Development

      • 11.16.2 Market Performance

      • 11.16.3 Product and Service Introduction

    • 11.17 Oncotelic

      • 11.17.1 Oncotelic Company Profile and Recent Development

      • 11.17.2 Market Performance

      • 11.17.3 Product and Service Introduction

    • 11.18 Idera Pharmaceuticals

      • 11.18.1 Idera Pharmaceuticals Company Profile and Recent Development

      • 11.18.2 Market Performance

      • 11.18.3 Product and Service Introduction

    • 11.19 Sillajen Biotherapeutics

      • 11.19.1 Sillajen Biotherapeutics Company Profile and Recent Development

      • 11.19.2 Market Performance

      • 11.19.3 Product and Service Introduction

    • 11.20 Oncosec

      • 11.20.1 Oncosec Company Profile and Recent Development

      • 11.20.2 Market Performance

      • 11.20.3 Product and Service Introduction

    • 11.21 Merck

      • 11.21.1 Merck Company Profile and Recent Development

      • 11.21.2 Market Performance

      • 11.21.3 Product and Service Introduction

    • 11.22 Intellia Therapeutics

      • 11.22.1 Intellia Therapeutics Company Profile and Recent Development

      • 11.22.2 Market Performance

      • 11.22.3 Product and Service Introduction

    • 11.23 Oncolytics Biotech

      • 11.23.1 Oncolytics Biotech Company Profile and Recent Development

      • 11.23.2 Market Performance

      • 11.23.3 Product and Service Introduction

    12 Data Source and Research Methodology

    The List of Tables and Figures (Totals 114 Figures and 194 Tables)

    • Figure Product Picture

    • Figure Gene Therapy in Oncology Market Size and Growth Rate of Ex Vivo from 2014 to 2026

    • Figure Gene Therapy in Oncology Market Size and Growth Rate of In Vivo from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global Gene Therapy in Oncology Market Size and Growth Rate of Hospitals from 2014 to 2026

    • Figure Global Gene Therapy in Oncology Market Size and Growth Rate of Diagnostics Centers from 2014 to 2026

    • Figure Global Gene Therapy in Oncology Market Size and Growth Rate of Research Institutes from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America Gene Therapy in Oncology Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States Gene Therapy in Oncology Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Gene Therapy in Oncology Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Gene Therapy in Oncology Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Gene Therapy in Oncology Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Gene Therapy in Oncology Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK Gene Therapy in Oncology Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France Gene Therapy in Oncology Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Gene Therapy in Oncology Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Gene Therapy in Oncology Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Gene Therapy in Oncology Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Gene Therapy in Oncology Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Gene Therapy in Oncology Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Gene Therapy in Oncology Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Gene Therapy in Oncology Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Gene Therapy in Oncology Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China Gene Therapy in Oncology Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Gene Therapy in Oncology Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand Gene Therapy in Oncology Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India Gene Therapy in Oncology Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Gene Therapy in Oncology Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Gene Therapy in Oncology Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa Gene Therapy in Oncology Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries Gene Therapy in Oncology Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Gene Therapy in Oncology Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria Gene Therapy in Oncology Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Gene Therapy in Oncology Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Gene Therapy in Oncology Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Gene Therapy in Oncology Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Gene Therapy in Oncology

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Gene Therapy in Oncology by Different Types from 2014 to 2026

    • Table Consumption Share of Gene Therapy in Oncology by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Ex Vivo

    • Figure Market Size and Growth Rate of In Vivo

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Gene Therapy in Oncology by Different End-Users from 2014 to 2026

    • Table Consumption Share of Gene Therapy in Oncology by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Hospitals

    • Figure Market Size and Growth Rate of Diagnostics Centers

    • Figure Market Size and Growth Rate of Research Institutes

    • Table Global Gene Therapy in Oncology Production by Major Regions

    • Table Global Gene Therapy in Oncology Production Share by Major Regions

    • Figure Global Gene Therapy in Oncology Production Share by Major Regions in 2014

    • Figure Global Gene Therapy in Oncology Production Share by Major Regions in 2018

    • Figure Global Gene Therapy in Oncology Production Share by Major Regions in 2026

    • Table Global Gene Therapy in Oncology Consumption by Major Regions

    • Table Global Gene Therapy in Oncology Consumption Share by Major Regions

    • Figure Global Gene Therapy in Oncology Consumption Share by Major Regions in 2014

    • Figure Global Gene Therapy in Oncology Consumption Share by Major Regions in 2018

    • Figure Global Gene Therapy in Oncology Consumption Share by Major Regions in 2026

    • Table North America Gene Therapy in Oncology Production, Import, Consumption and Export Analysis

    • Table Europe Gene Therapy in Oncology Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Gene Therapy in Oncology Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Gene Therapy in Oncology Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Gene Therapy in Oncology market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Gene Therapy in Oncology market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Gene Therapy in Oncology market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Gene Therapy in Oncology market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Gene Therapy in Oncology Consumption by Types from 2014 to 2026

    • Table North America Gene Therapy in Oncology Consumption Share by Types from 2014 to 2026

    • Figure North America Gene Therapy in Oncology Consumption Share by Types in 2014

    • Figure North America Gene Therapy in Oncology Consumption Share by Types in 2018

    • Figure North America Gene Therapy in Oncology Consumption Share by Types in 2026

    • Table North America Gene Therapy in Oncology Consumption by End-Users from 2014 to 2026

    • Table North America Gene Therapy in Oncology Consumption Share by End-Users from 2014 to 2026

    • Figure North America Gene Therapy in Oncology Consumption Share by End-Users in 2014

    • Figure North America Gene Therapy in Oncology Consumption Share by End-Users in 2018

    • Figure North America Gene Therapy in Oncology Consumption Share by End-Users in 2026

    • Table North America Gene Therapy in Oncology Consumption by Major Countries from 2014 to 2026

    • Table North America Gene Therapy in Oncology Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Gene Therapy in Oncology Consumption Share by Major Countries in 2014

    • Figure North America Gene Therapy in Oncology Consumption Share by Major Countries in 2018

    • Figure North America Gene Therapy in Oncology Consumption Share by Major Countries in 2026

    • Figure United States Gene Therapy in Oncology Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Gene Therapy in Oncology Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Gene Therapy in Oncology Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Gene Therapy in Oncology Consumption by Types from 2014 to 2026

    • Table Europe Gene Therapy in Oncology Consumption Share by Types from 2014 to 2026

    • Figure Europe Gene Therapy in Oncology Consumption Share by Types in 2014

    • Figure Europe Gene Therapy in Oncology Consumption Share by Types in 2018

    • Figure Europe Gene Therapy in Oncology Consumption Share by Types in 2026

    • Table Europe Gene Therapy in Oncology Consumption by End-Users from 2014 to 2026

    • Table Europe Gene Therapy in Oncology Consumption Share by End-Users from 2014 to 2026

    • Figure Europe Gene Therapy in Oncology Consumption Share by End-Users in 2014

    • Figure Europe Gene Therapy in Oncology Consumption Share by End-Users in 2018

    • Figure Europe Gene Therapy in Oncology Consumption Share by End-Users in 2026

    • Table Europe Gene Therapy in Oncology Consumption by Major Countries from 2014 to 2026

    • Table Europe Gene Therapy in Oncology Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe Gene Therapy in Oncology Consumption Share by Major Countries in 2014

    • Figure Europe Gene Therapy in Oncology Consumption Share by Major Countries in 2018

    • Figure Europe Gene Therapy in Oncology Consumption Share by Major Countries in 2026

    • Figure Germany Gene Therapy in Oncology Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Gene Therapy in Oncology Market Volume and Growth Rate from 2014 to 2026

    • Figure France Gene Therapy in Oncology Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Gene Therapy in Oncology Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Gene Therapy in Oncology Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Gene Therapy in Oncology Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Gene Therapy in Oncology Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Gene Therapy in Oncology Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Gene Therapy in Oncology Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Gene Therapy in Oncology Consumption by Types from 2014 to 2026

    • Table Asia Pacific Gene Therapy in Oncology Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific Gene Therapy in Oncology Consumption Share by Types in 2014

    • Figure Asia Pacific Gene Therapy in Oncology Consumption Share by Types in 2018

    • Figure Asia Pacific Gene Therapy in Oncology Consumption Share by Types in 2026

    • Table Asia Pacific Gene Therapy in Oncology Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific Gene Therapy in Oncology Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific Gene Therapy in Oncology Consumption Share by End-Users in 2014

    • Figure Asia Pacific Gene Therapy in Oncology Consumption Share by End-Users in 2018

    • Figure Asia Pacific Gene Therapy in Oncology Consumption Share by End-Users in 2026

    • Table Asia Pacific Gene Therapy in Oncology Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Gene Therapy in Oncology Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific Gene Therapy in Oncology Consumption Share by Major Countries in 2014

    • Figure Asia Pacific Gene Therapy in Oncology Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Gene Therapy in Oncology Consumption Share by Major Countries in 2026

    • Figure China Gene Therapy in Oncology Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Gene Therapy in Oncology Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandGene Therapy in Oncology Market Volume and Growth Rate from 2014 to 2026

    • Figure India Gene Therapy in Oncology Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Gene Therapy in Oncology Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Gene Therapy in Oncology Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Gene Therapy in Oncology Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa Gene Therapy in Oncology Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa Gene Therapy in Oncology Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa Gene Therapy in Oncology Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Gene Therapy in Oncology Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa Gene Therapy in Oncology Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa Gene Therapy in Oncology Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa Gene Therapy in Oncology Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa Gene Therapy in Oncology Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Gene Therapy in Oncology Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa Gene Therapy in Oncology Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Gene Therapy in Oncology Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa Gene Therapy in Oncology Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa Gene Therapy in Oncology Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Gene Therapy in Oncology Consumption Share by Major Countries in 2026

    • Figure GCC Countries Gene Therapy in Oncology Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Gene Therapy in Oncology Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria Gene Therapy in Oncology Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Gene Therapy in Oncology Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Gene Therapy in Oncology Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Editas Medicine

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Editas Medicine

    • Figure Sales and Growth Rate Analysis of Editas Medicine

    • Figure Revenue and Market Share Analysis of Editas Medicine

    • Table Product and Service Introduction of Editas Medicine

    • Table Company Profile and Development Status of Shenzhen SiBiono GeneTech

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shenzhen SiBiono GeneTech

    • Figure Sales and Growth Rate Analysis of Shenzhen SiBiono GeneTech

    • Figure Revenue and Market Share Analysis of Shenzhen SiBiono GeneTech

    • Table Product and Service Introduction of Shenzhen SiBiono GeneTech

    • Table Company Profile and Development Status of CRISPR Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CRISPR Therapeutics

    • Figure Sales and Growth Rate Analysis of CRISPR Therapeutics

    • Figure Revenue and Market Share Analysis of CRISPR Therapeutics

    • Table Product and Service Introduction of CRISPR Therapeutics

    • Table Company Profile and Development Status of Ziopharm Oncology

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ziopharm Oncology

    • Figure Sales and Growth Rate Analysis of Ziopharm Oncology

    • Figure Revenue and Market Share Analysis of Ziopharm Oncology

    • Table Product and Service Introduction of Ziopharm Oncology

    • Table Company Profile and Development Status of Bio-Path Holdings

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bio-Path Holdings

    • Figure Sales and Growth Rate Analysis of Bio-Path Holdings

    • Figure Revenue and Market Share Analysis of Bio-Path Holdings

    • Table Product and Service Introduction of Bio-Path Holdings

    • Table Company Profile and Development Status of Marsala Biotech

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Marsala Biotech

    • Figure Sales and Growth Rate Analysis of Marsala Biotech

    • Figure Revenue and Market Share Analysis of Marsala Biotech

    • Table Product and Service Introduction of Marsala Biotech

    • Table Company Profile and Development Status of Bristol-Myers Squibb

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb

    • Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb

    • Figure Revenue and Market Share Analysis of Bristol-Myers Squibb

    • Table Product and Service Introduction of Bristol-Myers Squibb

    • Table Company Profile and Development Status of Mologen AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mologen AG

    • Figure Sales and Growth Rate Analysis of Mologen AG

    • Figure Revenue and Market Share Analysis of Mologen AG

    • Table Product and Service Introduction of Mologen AG

    • Table Company Profile and Development Status of Advantagene

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Advantagene

    • Figure Sales and Growth Rate Analysis of Advantagene

    • Figure Revenue and Market Share Analysis of Advantagene

    • Table Product and Service Introduction of Advantagene

    • Table Company Profile and Development Status of AstraZeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

    • Figure Sales and Growth Rate Analysis of AstraZeneca

    • Figure Revenue and Market Share Analysis of AstraZeneca

    • Table Product and Service Introduction of AstraZeneca

    • Table Company Profile and Development Status of Geron Corp

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Geron Corp

    • Figure Sales and Growth Rate Analysis of Geron Corp

    • Figure Revenue and Market Share Analysis of Geron Corp

    • Table Product and Service Introduction of Geron Corp

    • Table Company Profile and Development Status of Tocagen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Tocagen

    • Figure Sales and Growth Rate Analysis of Tocagen

    • Figure Revenue and Market Share Analysis of Tocagen

    • Table Product and Service Introduction of Tocagen

    • Table Company Profile and Development Status of Johnson & Johnson

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson

    • Figure Sales and Growth Rate Analysis of Johnson & Johnson

    • Figure Revenue and Market Share Analysis of Johnson & Johnson

    • Table Product and Service Introduction of Johnson & Johnson

    • Table Company Profile and Development Status of UniQure

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of UniQure

    • Figure Sales and Growth Rate Analysis of UniQure

    • Figure Revenue and Market Share Analysis of UniQure

    • Table Product and Service Introduction of UniQure

    • Table Company Profile and Development Status of Cold Genesys

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cold Genesys

    • Figure Sales and Growth Rate Analysis of Cold Genesys

    • Figure Revenue and Market Share Analysis of Cold Genesys

    • Table Product and Service Introduction of Cold Genesys

    • Table Company Profile and Development Status of Amgen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen

    • Figure Sales and Growth Rate Analysis of Amgen

    • Figure Revenue and Market Share Analysis of Amgen

    • Table Product and Service Introduction of Amgen

    • Table Company Profile and Development Status of Oncotelic

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Oncotelic

    • Figure Sales and Growth Rate Analysis of Oncotelic

    • Figure Revenue and Market Share Analysis of Oncotelic

    • Table Product and Service Introduction of Oncotelic

    • Table Company Profile and Development Status of Idera Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Idera Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Idera Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Idera Pharmaceuticals

    • Table Product and Service Introduction of Idera Pharmaceuticals

    • Table Company Profile and Development Status of Sillajen Biotherapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sillajen Biotherapeutics

    • Figure Sales and Growth Rate Analysis of Sillajen Biotherapeutics

    • Figure Revenue and Market Share Analysis of Sillajen Biotherapeutics

    • Table Product and Service Introduction of Sillajen Biotherapeutics

    • Table Company Profile and Development Status of Oncosec

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Oncosec

    • Figure Sales and Growth Rate Analysis of Oncosec

    • Figure Revenue and Market Share Analysis of Oncosec

    • Table Product and Service Introduction of Oncosec

    • Table Company Profile and Development Status of Merck

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

    • Figure Sales and Growth Rate Analysis of Merck

    • Figure Revenue and Market Share Analysis of Merck

    • Table Product and Service Introduction of Merck

    • Table Company Profile and Development Status of Intellia Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Intellia Therapeutics

    • Figure Sales and Growth Rate Analysis of Intellia Therapeutics

    • Figure Revenue and Market Share Analysis of Intellia Therapeutics

    • Table Product and Service Introduction of Intellia Therapeutics

    • Table Company Profile and Development Status of Oncolytics Biotech

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Oncolytics Biotech

    • Figure Sales and Growth Rate Analysis of Oncolytics Biotech

    • Figure Revenue and Market Share Analysis of Oncolytics Biotech

    • Table Product and Service Introduction of Oncolytics Biotech


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.